Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
David S. Khoury, Adam K. Wheatley, Mitchell D. Ramuta, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 12, pp. 727-738
Open Access | Times Cited: 122

Showing 26-50 of 122 citing articles:

Animal models of disease: Achievements and challenges
José Manuel Bravo‐San Pedro, Fernando Aranda, Aitziber Buqué, et al.
Methods in cell biology (2025), pp. xv-xxi
Closed Access
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients
Lisa Blixt, Gordana Bogdanović, Marcus Buggert, et al.
Leukemia (2021) Vol. 36, Iss. 2, pp. 476-481
Open Access | Times Cited: 39
What level of neutralising antibody protects from COVID-19?
David S. Khoury, Deborah Cromer, Arnold Reynaldi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 38
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay
Ester López, Ebene R. Haycroft, Amy Adair, et al.
JCI Insight (2021) Vol. 6, Iss. 16
Open Access | Times Cited: 37
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
Thomas S. Fulford, Huy Trần Văn, Nicholas A. Gherardin, et al.
EBioMedicine (2021) Vol. 74, pp. 103729-103729
Open Access | Times Cited: 35
Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates
Nivedita Gupta, Labanya Mukhopadhyay, Pragya D. Yadav, et al.
The Indian Journal of Medical Research (2021) Vol. 153, Iss. 1, pp. 93-93
Open Access | Times Cited: 32
SARS-CoV-2 remodels the Golgi apparatus to facilitate viral assembly and secretion
Jianchao Zhang, Andrew A. Kennedy, Daniel Macedo de Melo Jorge, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 22
Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2
Ingrid Horbach, Adriana de Souza Azevedo, Waleska Dias Schwarcz, et al.
Diseases (2024) Vol. 12, Iss. 1, pp. 29-29
Open Access | Times Cited: 4
Predicting Vaccine Effectiveness for Hospitalization and Symptomatic Disease for Novel SARS-CoV-2 Variants Using Neutralizing Antibody Titers
Billy J. Gardner, A. Marm Kilpatrick
Viruses (2024) Vol. 16, Iss. 3, pp. 479-479
Open Access | Times Cited: 4
Dynamic Profiling and Prediction of Antibody Response to SARS-CoV-2 Booster-Inactivated Vaccines by Microsample-Driven Biosensor and Machine Learning
Sumin Bian, Min Shang, Ying Tao, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 352-352
Open Access | Times Cited: 4
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
Payton A. Weidenbacher, Eric Waltari, Izumi de los Rios Kobara, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 11, pp. 1270-1276
Open Access | Times Cited: 20
Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns
Ilhan Tomris, Kim M. Bouwman, Youri Adolfs, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 3, pp. e1010340-e1010340
Open Access | Times Cited: 19
Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2
Paula Sanz‐Leon, Lachlan Hamilton, Sebastian J. Raison, et al.
Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences (2022) Vol. 380, Iss. 2233
Open Access | Times Cited: 19
Predicting unseen antibodies’ neutralizability via adaptive graph neural networks
Jie Zhang, Yishan Du, Pengfei Zhou, et al.
Nature Machine Intelligence (2022) Vol. 4, Iss. 11, pp. 964-976
Open Access | Times Cited: 19
Evaluation of Two Rapid Lateral Flow Tests and Two Surrogate ELISAs for the Detection of SARS-CoV-2 Specific Neutralizing Antibodies
Philipp Girl, Katrin Zwirglmaier, Heiner von Buttlar, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 18
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Deborah Cromer, Arnold Reynaldi, Ainslie Mitchell, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Proteases and variants: context matters for SARS-CoV-2 entry assays
Christian S. Stevens, Kasopefoluwa Y. Oguntuyo, Benhur Lee
Current Opinion in Virology (2021) Vol. 50, pp. 49-58
Open Access | Times Cited: 26
SARS-CoV-2 variants: levels of neutralisation required for protective immunity
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 26
COVID-19 Research: Lessons from Non-Human Primate Models
Laure Albrecht, Elodie Bishop, Basile Jay, et al.
Vaccines (2021) Vol. 9, Iss. 8, pp. 886-886
Open Access | Times Cited: 26
The role of pseudotype neutralization assays in understanding SARS CoV-2
Diego Cantoni, Martin Mayora‐Neto, Nigel Temperton
Oxford Open Immunology (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 25
SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods
Elitza S. Theel, Patrick W. Johnson, Katie L. Kunze, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 9
Open Access | Times Cited: 24
Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations
Maura Pugliatti, Thomas Berger, Hans‐Peter Hartung, et al.
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 319-327
Closed Access | Times Cited: 18
Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History
Maciej Tarkowski, Wilco de Jager, Marco Schiuma, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 22
MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
Clement A. Meseda, Charles B. Stauft, Prabhuanand Selvaraj, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 20
Cell and Animal Models for SARS-CoV-2 Research
Eloïne Bestion, Philippe Halfon, Soraya Mezouar, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1507-1507
Open Access | Times Cited: 14

Scroll to top